We demonstrated previously that food intake traits map to a quantitative trait locus (QTL) on proximal chromosome 17, which encompasses Glp1r (glucagon-like peptide 1 receptor), encoding an important modulator of gastric emptying. We then confirmed this QTL in a B6.CAST-17 congenic strain that consumed 27% more carbohydrate and 17% more total calories, yet similar fat calories, per body weight compared with the recipient C57BL/6J. The congenic strain also consumed greater food volume. The current aims were to 1) identify genetic linkage for total food volume in F 2 mice, 2) perform gene expression profiling in stomach of B6.CAST-17 congenic mice using oligonucleotide arrays, 3) test for allelic imbalance in Glp1r expression, 4) evaluate gastric emptying rate in parental and congenic mice, and 5) investigate a possible effect of genetic variation in Glp1r on gastric emptying. A genome scan revealed a single QTL for total food volume (Tfv1) (log of the odds ratio ϭ 7.6), which was confirmed in B6.CAST-17 congenic mice. Glp1r exhibited allelic imbalance in stomach, which correlated with accelerated gastric emptying in parental CAST and congenic B6.CAST-17 mice. Moreover, congenic mice displayed an impaired gastric emptying response to exendin-(9-39). These results suggest that genetic variation in Glp1r contributes to the strain differences in gastric emptying rate.quantitative trait locus; glucagon-like peptide 1 receptor THE GUT HORMONE GLUCAGON-LIKE PEPTIDE 1 (GLP-1) inhibits gastric emptying, reduces postprandial gastric secretion, and may play a physiological role in regulating appetite and energy intake. Systemic administration of GLP-1 in physiological amounts in both humans and animals potently inhibits gastric emptying (9,13,15,31,59,61), and this effect can be blocked by administration of the GLP-1 receptor antagonist exendin (9-39) (21). The mechanism by which GLP-1 inhibits gastric emptying is thought to involve receptors located either in the central nervous system or associated with afferent pathways to the brain stem (9,21,60). In addition to the deceleration of gastric emptying, GLP-1 is involved in regulating satiety, as shown in normal-weight and obese men infused with 33,34). GLP-1 also decreases food intake; by contrast, central administration of the GLP-1 receptor (GLP-1R) antagonist exendin-(9-39) stimulates food intake (14, 54).The GLP-1R is a seven-transmembrane domain receptor belonging to the B family of G-protein-coupled receptors (6, 52). The GLP-1R recognizes GLP-1 specifically and does not show demonstrable binding by related peptides (Ref. 52; for review, see Ref. 6). In rodents, GLP-1 receptor mRNA and high-affinity GLP-1 binding sites have been identified in pancreatic islets, in gastrointestinal tract, in lung, in kidney, in heart, and throughout the brain (7,8,16). The satiety-promoting effects of GLP-1 implicate Glp1r as a physiological gene candidate for ingestive behavior phenotypes (1).Glp1r maps to the peak of a genetic region containing overlapping quantitative trait loci (Q...